Brief: Verve Therapeutics Q3 EPS USD -0.59
Nov 05 (Reuters) - Verve Therapeutics Q3 net income USD -50.133 million. * Q3 collaboration revenue USD 6.865 million
Nov 05 (Reuters) - Verve Therapeutics Q3 net income USD -50.133 million. * Q3 collaboration revenue USD 6.865 million